A share price of Fortress Biotech Inc [FBIO] is currently trading at $2.98, up 15.50%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The FBIO shares have gain 30.13% over the last week, with a monthly amount glided 64.64%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Ladenburg Thalmann started tracking the stock with Buy rating on August 04, 2022, and set its price target to $6. On October 02, 2020, The Benchmark Company initiated with a Buy rating and assigned a price target of $9 on the stock. B. Riley FBR started tracking the stock assigning a Buy rating and suggested a price target of $9 on December 18, 2019. B. Riley FBR Inc. initiated its recommendation with a Buy and recommended $10 as its price target on February 28, 2018. Rodman & Renshaw started tracking with a Buy rating for this stock on July 11, 2017, and assigned it a price target of $11. In a note dated March 22, 2017, JMP Securities initiated an Mkt Outperform rating.
Fortress Biotech Inc experienced fluctuations in its stock price throughout the past year between $1.33 and $2.67. Fortress Biotech Inc [NASDAQ: FBIO] shares were valued at $2.98 at the most recent close of the market.
Analyzing the FBIO fundamentals
Trailing Twelve Months sales for Fortress Biotech Inc [NASDAQ:FBIO] were 59.30M which represents 10.18% growth. Gross Profit Margin for this corporation currently stands at 0.71% with Operating Profit Margin at -1.77%, Pretax Profit Margin comes in at -1.5%, and Net Profit Margin reading is -0.25%. To continue investigating profitability, this company’s Return on Assets is posted at -0.09, Equity is -0.54 and Total Capital is -1.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.58.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.77 points at the first support level, and at 2.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.14, and for the 2nd resistance point, it is at 3.29.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Fortress Biotech Inc [NASDAQ:FBIO] is 1.92. Further, the Quick Ratio stands at 1.70, while the Cash Ratio is 1.29. Considering the valuation of this stock, the price to sales ratio is 1.50, the price to book ratio is 2.02.
Transactions by insiders
Recent insider trading involved Fortress Biotech, Inc., 10% Owner, that happened on May 29 ’25 when 100000.0 shares were sold. PRESIDENT, CEO & CHAIRMAN, ROSENWALD LINDSAY A MD completed a deal on Sep 23 ’24 to buy 0.76 million shares.
